Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Sepsis

Preventing organ failure in sepsis — the search continues

In a recent trial, levosimendan therapy failed to ameliorate sepsis-induced organ dysfunction or improve the survival of patients with septic shock. The failure of levosimendan and many other potential therapies for sepsis, together with the findings of histopathologic studies, raise questions regarding the pathophysiologic basis of the disorder.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Current theories of the pathophysiological mechanisms that underlie organ failure in sepsis.

References

  1. Dellinger, R. P. et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock:2012. Crit. Care Med. 41, 580–637 (2012).

    Article  Google Scholar 

  2. Gordon, A. C. et al. Levosimendan for the prevention of acute organ dysfunction in sepsis. N. Engl. J. Med. http://dx.doi.org/10.1056/NEJMoa1609409 (2016).

  3. Hawiger, J., Veach, R. A. & Zienkiewicz, J. New paradigms in sepsis: from prevention to protection of failing microcirculation. J. Thromb. Haemost. 13, 1743–1756 (2015).

    Article  CAS  Google Scholar 

  4. Marik, P. E. The demise of early goal-directed therapy for severe sepsis and septic shock. Acta Anaesthesiol. Scand. 59, 561–567 (2015).

    Article  CAS  Google Scholar 

  5. Morelli, A. et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310, 1683–1691 (2013).

    Article  Google Scholar 

  6. Mira, J. C. et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit. Care Med. http://dx.doi.org/10.1097/ccm.0000000000002074 (2016).

  7. Hotchkiss, R. S. et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27, 1230–1251 (1999).

    Article  CAS  Google Scholar 

  8. Takasu, O. et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am. J. Respir. Crit. Care Med. 187, 509–517 (2013).

    Article  CAS  Google Scholar 

  9. Hotchkiss, R. S. & Moldawer, L. L. Parallels between cancer and infectious disease. N. Engl. J. Med. 371, 380–383 (2014).

    Article  Google Scholar 

  10. Hotchkiss, R. S. & Opal, S. Immunotherapy for sepsis — a new approach against an ancient foe. N. Engl. J. Med. 363, 87–89 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard S. Hotchkiss.

Ethics declarations

Competing interests

R.S.H. has received grant support from Medimmune, Bristol-Myers Squibb, and GlaxoSmithKline. T.J.G. declares no competing interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Graetz, T., Hotchkiss, R. Preventing organ failure in sepsis — the search continues. Nat Rev Nephrol 13, 5–6 (2017). https://doi.org/10.1038/nrneph.2016.171

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2016.171

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing